0
0
India’s food regulator has ordered a nationwide clean‑up of beverages misusing the powerful “ORS” label, in a move aimed at protecting consumers from drinks that look like medical oral rehydration solutions but do not meet World Health Organization (WHO) standards. The Food Safety and Standards Authority of India (FSSAI) has directed immediate removal of such products from retail shelves and e‑commerce platforms, while explicitly safeguarding the availability of genuine WHO‑recommended ORS used to treat dehydration.
What FSSAI Has Ordered
FSSAI’s latest directive targets fruit‑based beverages, ready‑to‑serve drinks, energy and “electrolyte” drinks, and similar products that use “ORS” in their brand or product names despite being regulated as foods, not medicines. The regulator has asked enforcement officers to inspect retail outlets and online marketplaces, identify non‑compliant products, remove them from sale, and initiate regulatory action against manufacturers, with detailed action‑taken reports to be submitted.
The order follows earlier instructions issued on October 14 and clarified on October 15, 2025, which withdrew permission for any food product—fruit‑based, non‑carbonated, or ready‑to‑drink—to use the term “ORS” in any form, including as a prefix or suffix in trademarks or brand names. FSSAI has reiterated that using “ORS” on such beverages violates provisions of the Food Safety and Standards Act, 2006, especially those prohibiting misbranding and misleading claims.
Why The “ORS” Label Matters
Oral Rehydration Solution (ORS) is not just another “electrolyte drink”; it is a precisely formulated medical intervention recommended by WHO and UNICEF for the treatment of dehydration due to diarrhoea and vomiting. Standard low‑osmolarity WHO‑ORS contains specific concentrations of glucose, sodium, potassium, chloride, and citrate, with a total osmolarity of about 245 mOsm/L, designed to optimise fluid and electrolyte absorption in the gut.
WHO and UNICEF recommend a low‑osmolarity ORS formula in which glucose and sodium are balanced to promote water uptake via the sodium‑glucose co‑transport mechanism, reducing stool output and vomiting compared with older, higher‑osmolarity preparations. Deviating significantly from this composition—for example, by adding large amounts of sugar or altering electrolyte ratios—can impair absorption and, in some cases, worsen dehydration or metabolic disturbances, particularly in children, older adults, and people with diabetes.
Public Health Risks From Misleading Drinks
Regulators and courts have raised particular concern that many “ORS‑like” beverages sold in India are essentially sugary, flavoured drinks with unbalanced electrolytes being marketed in pharmacies and grocery stores as if they were therapeutic ORS. A Delhi High Court bench noted that several products using “ORS” in their brand names were high‑sugar, flavoured or fruit‑based drinks that did not match WHO‑recommended ORS composition and could aggravate dehydration in children, the elderly and people with diabetes.
The court characterised such misbranding as a serious public health risk and affirmed that public health must take precedence over commercial interests, refusing to interfere with FSSAI’s prohibition on the use of “ORS” for beverages that are not true oral rehydration solutions. Public health experts have similarly warned that in low‑resource settings, caregivers may believe they are buying life‑saving ORS for a child with diarrhoea when they are actually purchasing a sweetened drink that may not correct fluid and electrolyte losses adequately.
Genuine ORS Products Remain Protected
Importantly, FSSAI has clarified that enforcement action must not interfere with the manufacturing, storage, distribution, or sale of WHO‑recommended ORS products that are regulated as drugs and used under medical and public health programmes. These genuine ORS products follow pharmacopoeial standards aligned with WHO and UNICEF guidance and remain central to diarrhoea management protocols endorsed by agencies such as Médecins Sans Frontières and national child health programmes.
Oral rehydration therapy using appropriate ORS is considered a first‑line, life‑saving intervention in gastroenteritis and other causes of acute diarrhoea, substantially reducing mortality, especially among young children. Clinical and programmatic data show that properly used ORS can prevent most cases of severe dehydration and the need for intravenous fluids, making it critical that the term “ORS” is reserved for products that meet established therapeutic standards.
Expert Perspective: “Words On The Label Can Be Life‑Critical”
Paediatric and internal medicine specialists not involved in the FSSAI orders emphasise that the decision is less about policing brands and more about protecting the treatment pathway for dehydration. Clinicians stress that when families see “ORS” printed on a pack, they assume the product will work like the ORS recommended in hospital discharge instructions or national diarrhoea control guidelines.
Experts point out that drinks with high sugar and low sodium may taste pleasant and appear hydrating but can draw water into the gut rather than into the bloodstream, leading to continued or worsening diarrhoea in some patients. They also note that people with diabetes are particularly vulnerable to hyperglycaemia and osmotic diuresis if they rely on very sugary beverages instead of medically appropriate ORS solutions during illness.
How This Affects Consumers And Industry
For consumers, the immediate impact is likely to be a reshaping of what appears on pharmacy shelves, supermarket aisles and e‑commerce listings under “ORS” or “electrolyte” categories. Products that do not meet WHO‑compliant ORS specifications but have historically leaned on “ORS”‑like branding may need to re‑label, reformulate, or reposition themselves as flavoured drinks or sports beverages rather than therapeutic solutions.
Industry stakeholders who previously relied on composite trademarks including “ORS” had enjoyed greater flexibility after a 2024 clarification that allowed such use under strict labelling conditions, but the October 2025 orders have now effectively closed that pathway to prevent consumer confusion. Companies may still market electrolyte or hydration drinks, but they will need to avoid the “ORS” expression unless they align with WHO‑recommended formulations and relevant drug regulations, which involve more stringent quality and pharmacovigilance requirements.
Limitations, Legal Challenges And Ongoing Debate
Not all stakeholders agree on how far the restrictions should go, and some manufacturers have approached the courts seeking relief, arguing that their products are safe beverages and that branding constraints hurt established trademarks. In at least one case, the Delhi High Court granted interim relief allowing sale of existing stock of an ORS‑like beverage while the broader regulatory issues continue to be litigated, underscoring the evolving nature of this policy space.
Public health advocates note that enforcement alone may not fully address the problem if consumers are not educated about the difference between WHO‑compliant ORS and commercial electrolyte or energy drinks. They argue for large‑scale awareness campaigns that explain when to use medical ORS, when a simple homemade solution (such as correctly prepared salt‑sugar solution) may be appropriate, and when branded beverages are merely for taste and mild hydration rather than treatment of illness.
Practical Takeaways For Readers
For families and individuals, one of the most important steps is to recognise that not every “electrolyte” or “rehydration” drink is a medical ORS suitable for treating diarrhoea or vomiting. When a doctor, nurse or health worker recommends ORS, they are typically referring to WHO‑standard ORS sachets or solutions with clearly stated composition, usually dispensed through pharmacies or health programmes and labelled according to drug regulations rather than as general foods.
Consumers can protect themselves by reading labels carefully, checking for WHO‑aligned composition (including sodium and glucose amounts) and seeking advice from qualified healthcare professionals, especially when managing dehydration in children, older adults, pregnant people, or those with chronic illnesses. In case of doubt, consulting a doctor or accredited health worker before relying on a packaged “ORS‑like” drink for illness‑related dehydration remains the safest course of action.
“Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.”
References
